Pay in 4 interest-free payments of $7.01 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
Key Market Highlights The global GLP-1 analogues market was valued at US$ 51.6 Billion in 2024 The market is expected to reach US$ 211.8 Billion by 2035 The industry is forecast to expand at a CAGR of 13.7% during 2025-2035 North America accounted for the largest market share of 68.4% in 2024 The Subcutaneous route of administration segment held 78.2% market share in 2024 Major industry participants include Novo Nordisk A/S, Eli Lilly and Company, Sanofi, and AstraZeneca Rising Type 2 Diabetes Cases Accelerating Market Growth The growing prevalence of type 2 diabetes remains one of the most significant growth drivers for the GLP-1 analogues market
Tables 2-4 summarize data about ADCs in NSCLC
The agents comprehensive benefits render it an instrumental option for individuals aiming to achieve both significant weight reduction and heightened cardio protection
The remaining 35 full-text articles were assessed for eligibility
Heres what you need to know Wondering if you have to take GLP-1s forever
Our team is dedicated to providing personalized support, verifying insurance coverage, and assisting with documentation to ensure you receive the treatment you need
US$ 29.65
US$ 22.62
US$ 22.77
US$ 22.36
US$ 22.41
